the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION

NCT ID: NCT02088424

Last Updated: 2014-03-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

THE INSULIN RESISTANCE IN RECURRENT ABORTION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

THE ROLE OF INSULIN RESISTANCE IN RECURRENT ABORTION

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Recurrent Abortion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A

cases with recurrent abortion with insulin resisance

insulin resistance(fasting glucose/fasting insulin)

Intervention Type OTHER

insulin resistance(fasting glucose/fasting insulin )

GROUP B

cases that are pregnant with no history of recurrent abortion with no insulin resistance

insulin resistance(fasting glucose/fasting insulin)

Intervention Type OTHER

insulin resistance(fasting glucose/fasting insulin )

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

insulin resistance(fasting glucose/fasting insulin)

insulin resistance(fasting glucose/fasting insulin )

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Women in the child bearing period between 23-40 years.
2. All patients are pregnant.
3. The gestational age of both groups 6-13 weeks

Exclusion Criteria

1. Patients with gestational diabetes and gestational impaired glucose tolerance.
2. The patients who took medication that could affect glucose metabolism at the time of the study
3. Patients with other causes of recurrent abortion as(thyroid dysfunction, uterine anomalies chromosomal abnormalities, antiphspholipid antibody syndrome, uterine anomalies and TORCH syndrome).
4. Patients with PCOS.
5. Obese patients(BMI\>30)
Minimum Eligible Age

23 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

mohamed ahmed selem

THE ROLE OF INSULIN RESISTANCE IN RECURRENT MISCARRIAGE

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain shams maternity hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

mohamed a selem, master

Role: CONTACT

00201116724786

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

ABDELLATIF G ELKHOLY, M D

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

mohd-1978

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.